Clin2
NCT07830303Possibly a fitNot yet recruiting

Sleep medication for adults with liver cirrhosis and insomnia

Liver CirrhosisSleep DisturbanceHepatic Encephalopathy

Treatments studied

Part of Brain & nervous system, Digestive system, Hormones & metabolism, Mental health clinical trials.

This trial tests a new sleep medication called daridorexant for people with liver cirrhosis who also have trouble sleeping. The study aims to see if the drug improves sleep quality and is safe for this group.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
180 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must be between 18 and 60 years old.
  • You must have a confirmed diagnosis of liver cirrhosis (with mild to moderate liver function, class A or B).
  • You must have insomnia, proven by a sleep questionnaire and a sleep study or activity monitor.
  • You cannot have severe liver failure (class C) or severe brain issues from liver disease.
  • You cannot be taking certain other medications (like itraconazole, ketoconazole, carbamazepine, or rifampin), or central nervous system depressants (like alcohol, benzodiazepines, or opioids).
  • You cannot have severe breathing problems, uncontrolled sleep apnea, narcolepsy, or be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07733414Not yet recruiting· Phase 4
Switching from sleeping pills to daridorexant for insomnia

This study tests whether switching from common sleeping pills (BZRAs) to a newer medicine called daridorexant helps people with insomnia sleep better and feel better during the day. It is for adults who are not fully satisfied with their current sleeping pill or have side effects from it.

Beijing, Beijing Municipality
NCT07847021Not yet recruiting
Daridorexant for adults with insomnia

This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.

Chaohu, Anhui
NCT07701928Not yet recruiting· Phase 2
Sleep medication for insomnia and alcohol use disorder

This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.

Spokane, Washington
NCT07532252Not yet recruiting· Phase 2
Medication for alcohol problems and sleep

This study tests whether a medication called daridorexant helps people with alcohol use disorder by improving their sleep and possibly helping them reduce or stop drinking. If you have trouble sleeping and want to cut back on alcohol, this trial might be a fit.

NCT07555743Not yet recruiting· Phase 4
Sleep drug test for people with depression and insomnia

This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.

Barcelona, Catalonia
NCT07843329Not yet recruiting· Phase 3
Daridorexant for insomnia to improve sleep and daytime function

This trial tests a new medicine, daridorexant, to see if it helps people with insomnia sleep better through the night and feel more alert during the day. The study will use a home device to check your sleep patterns before you join.

Hear when a new Liver Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.